CN112415188B - 一种磁细胞及其制备方法和应用 - Google Patents
一种磁细胞及其制备方法和应用 Download PDFInfo
- Publication number
- CN112415188B CN112415188B CN202011338708.XA CN202011338708A CN112415188B CN 112415188 B CN112415188 B CN 112415188B CN 202011338708 A CN202011338708 A CN 202011338708A CN 112415188 B CN112415188 B CN 112415188B
- Authority
- CN
- China
- Prior art keywords
- magnetic
- cells
- cell
- magnetic beads
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 239000011324 bead Substances 0.000 claims abstract description 136
- 238000000034 method Methods 0.000 claims abstract description 51
- 239000000427 antigen Substances 0.000 claims abstract description 42
- 102000036639 antigens Human genes 0.000 claims abstract description 42
- 108091007433 antigens Proteins 0.000 claims abstract description 42
- 108010052285 Membrane Proteins Proteins 0.000 claims abstract description 40
- 102000018697 Membrane Proteins Human genes 0.000 claims abstract description 37
- 238000001514 detection method Methods 0.000 claims abstract description 31
- 125000000524 functional group Chemical group 0.000 claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 8
- 210000004027 cell Anatomy 0.000 claims description 179
- 239000013612 plasmid Substances 0.000 claims description 35
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 15
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 14
- 238000001890 transfection Methods 0.000 claims description 9
- 101710191617 Antigenic membrane protein Proteins 0.000 claims description 7
- 230000036046 immunoreaction Effects 0.000 claims description 7
- 238000011534 incubation Methods 0.000 claims description 7
- 108010036280 Aquaporin 4 Proteins 0.000 claims description 6
- 102000012002 Aquaporin 4 Human genes 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 241000283707 Capra Species 0.000 claims description 5
- 230000001464 adherent effect Effects 0.000 claims description 4
- 239000013613 expression plasmid Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000003018 immunoassay Methods 0.000 abstract description 10
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 210000002966 serum Anatomy 0.000 description 26
- 239000000243 solution Substances 0.000 description 18
- 108090000623 proteins and genes Proteins 0.000 description 14
- 239000008055 phosphate buffer solution Substances 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 10
- 239000001963 growth medium Substances 0.000 description 9
- 239000000523 sample Substances 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 238000000926 separation method Methods 0.000 description 7
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 6
- 238000000423 cell based assay Methods 0.000 description 6
- 238000007885 magnetic separation Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 229920002873 Polyethylenimine Polymers 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000010166 immunofluorescence Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- IGAZHQIYONOHQN-UHFFFAOYSA-N Alexa Fluor 555 Chemical compound C=12C=CC(=N)C(S(O)(=O)=O)=C2OC2=C(S(O)(=O)=O)C(N)=CC=C2C=1C1=CC=C(C(O)=O)C=C1C(O)=O IGAZHQIYONOHQN-UHFFFAOYSA-N 0.000 description 4
- 102100040501 Contactin-associated protein 1 Human genes 0.000 description 4
- 101710196304 Contactin-associated protein 1 Proteins 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 241000499489 Castor canadensis Species 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 235000011779 Menyanthes trifoliata Nutrition 0.000 description 2
- 101710160107 Outer membrane protein A Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000003119 immunoblot Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003147 molecular marker Substances 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 101150073415 Aqp4 gene Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 101150063416 add gene Proteins 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000012487 rinsing solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000012096 transfection reagent Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011338708.XA CN112415188B (zh) | 2020-11-25 | 2020-11-25 | 一种磁细胞及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011338708.XA CN112415188B (zh) | 2020-11-25 | 2020-11-25 | 一种磁细胞及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112415188A CN112415188A (zh) | 2021-02-26 |
CN112415188B true CN112415188B (zh) | 2022-10-04 |
Family
ID=74843508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011338708.XA Active CN112415188B (zh) | 2020-11-25 | 2020-11-25 | 一种磁细胞及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112415188B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116200414A (zh) * | 2022-08-31 | 2023-06-02 | 天津华科泰生物技术有限公司 | 一种重组人髓鞘少突胶质细胞糖蛋白及其制备方法和应用 |
CN115386595A (zh) * | 2022-09-05 | 2022-11-25 | 安徽大学 | 一种感染细胞的方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11667906B2 (en) * | 2014-11-24 | 2023-06-06 | Corning Incorporated | Magnetic microcarriers |
CN105738629B (zh) * | 2015-12-28 | 2018-07-10 | 中华人民共和国上海出入境检验检疫局 | 一种黄热病毒IgG抗体的间接免疫荧光检测方法 |
CN105624081A (zh) * | 2016-01-26 | 2016-06-01 | 北京中科圆融生物科技发展有限公司 | 表达特定重组蛋白的功能化细菌磁颗粒及其制备方法 |
US11591718B2 (en) * | 2018-04-27 | 2023-02-28 | Aimed Bio Inc. | Magnetic-based biopanning method through attachment of magnetic bead to cell |
US20200096503A1 (en) * | 2018-09-26 | 2020-03-26 | The Board Of Trustees Of The University Of Alabama | Cell membrane coated magnetic nanoparticles and assays for identification of transmembrane protein-binding compounds |
CN109593719A (zh) * | 2018-12-27 | 2019-04-09 | 桂林理工大学 | 一种将氧化铁纳米粒子吸附于细胞膜上的方法 |
-
2020
- 2020-11-25 CN CN202011338708.XA patent/CN112415188B/zh active Active
Non-Patent Citations (1)
Title |
---|
海洋弧菌的检测技术研究进展;张锐等;《中国环境科学学会学术年会论文集》;20171213;第4549-4556页 * |
Also Published As
Publication number | Publication date |
---|---|
CN112415188A (zh) | 2021-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005333157B2 (en) | Microbubbles for affinity separation | |
JP5656339B2 (ja) | タンパク質固定化担体およびその製造方法 | |
AU713352B2 (en) | Novel system for isolating and identifying eukaryotic cells transfected with genes and vectors | |
CN112415188B (zh) | 一种磁细胞及其制备方法和应用 | |
WO1997008186A9 (en) | Novel system for isolating and identifying eukaryotic cells transfected with genes and vectors | |
JP3363166B2 (ja) | 相互に対する極めて高い特異的親和性を有するペプチド対をイン・ビトロ診断分野に使用する方法 | |
JP2023011764A (ja) | レクチンの固定化方法 | |
JP4866977B2 (ja) | 抗梅毒トレポネーマ抗体測定試薬 | |
Howell et al. | Immunoisolation using magnetic solid supports: subcellular fractionation for cell-free functional studies | |
KR20190067779A (ko) | 다른 방식으로 항원을 고정화한 항원 담지 불용성 담체 입자를 사용하는 항체 측정법, 항체 측정용 시약 | |
CN117030991A (zh) | 细胞外囊泡检测装置及检测方法 | |
CN108663523A (zh) | 可用于诊断人肠道病毒71型感染的试剂盒 | |
GB2338483A (en) | Forming holes in cell membranes | |
US20060166377A1 (en) | Particle for magnetically induced membrane transport | |
JP3864194B2 (ja) | 複数の亜型が存在する抗原の共通抗原決定基に特異的な抗体の測定法ならびに測定試薬 | |
KR101395398B1 (ko) | 바이러스-마이크로비드 복합체 및 이의 용도 | |
AU620838B2 (en) | Process for producing magnetically responsive polymer particles and application thereof | |
JPH11504208A (ja) | レパートリークローニング法、それから得られる産物及びその産物の使用 | |
SCHMID et al. | KATHRYN E. HOWELL |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240719 Address after: Room 412, 4th Floor, Building 1, No. 18 Tianrong Street, Daxing Biomedical Industry Base, Zhongguancun Science and Technology Park, Daxing District, Beijing 102600 Patentee after: Beijing Jingyi Medical Laboratory Co.,Ltd. Country or region after: China Address before: No. 45 Changchun Street, Xicheng District, Beijing 100053 Patentee before: XUANWU HOSPITAL CAPITAL MEDICAL University Country or region before: China |
|
TR01 | Transfer of patent right |